Kim Hee-Kwon, Javed Muhammad Rashed, Chen Supin, Zettlitz Kirstin A, Collins Jeffrey, Wu Anna M, Kim Chang-Jin C J, Michael van Dam R, Keng Pei Yuin
Department of Molecular and Medical Pharmacology, University of California, Los Angeles Los Angeles CA 90095 USA.
Crump Institute for Molecular Imaging, University of California, Los Angeles Los Angeles CA 90095 USA.
RSC Adv. 2019 Oct 9;9(55):32175-32183. doi: 10.1039/c9ra06158d. eCollection 2019 Oct 7.
An all-electronic, droplet-based batch microfluidic device, operated using the electrowetting on dielectric (EWOD) mechanism was developed for on-demand synthesis of -succinimidyl-4-[F]fluorobenzoate ([F]SFB), the most commonly used F-prosthetic group for biomolecule labeling. In order to facilitate the development of peptides, and proteins as new diagnostic and therapeutic agents, we have diversified the compact EWOD microfluidic platform to perform the three-step radiosynthesis of [F]SFB starting from the no carrier added [F]fluoride ion. In this report, we established an optimal microliter droplet reaction condition to obtain reliable yields and synthesized [F]SFB with sufficient radioactivity for subsequent conjugation to the anti-PSCA cys-diabody (A2cDb) and for small animal imaging. The three-step, one-pot radiosynthesis of [F]SFB radiochemistry was adapted to a batch microfluidic platform with a reaction droplet sandwiched between two parallel plates of an EWOD chip, and optimized. Specifically, the ratio of precursor to base, droplet volume, reagent concentration, reaction time, and evaporation time were found be to be critical parameters. [F]SFB was successfully synthesized on the EWOD chip in 39 ± 7% ( = 4) radiochemical yield in a total synthesis time of ∼120 min ([F]fluoride activation, [F]fluorination, hydrolysis, and coupling reaction, HPLC purification, drying and reformulation). The reformulation and stabilization step for [F]SFB was important to obtain a high protein labeling efficiency of 33.1 ± 12.5% ( = 3). A small-animal immunoPET pilot study demonstrated that the [F]SFB-PSCA diabody conjugate showed specific uptake in the PSCA-positive human prostate cancer xenograft. The successful development of a compact footprint of the EWOD radiosynthesizer has the potential to empower biologists to produce PET probes of interest themselves in a standard laboratory.
开发了一种全电子、基于液滴的批量微流控装置,该装置利用介电电泳(EWOD)机制运行,用于按需合成N-琥珀酰亚胺基-4-[F]氟苯甲酸酯([F]SFB),这是生物分子标记中最常用的F- Prosthetic基团。为了促进肽和蛋白质作为新型诊断和治疗剂的开发,我们对紧凑的EWOD微流控平台进行了多样化改进,以从无载体添加的[F]氟离子开始进行[F]SFB的三步放射性合成。在本报告中,我们建立了最佳微升液滴反应条件以获得可靠的产率,并合成了具有足够放射性的[F]SFB,用于随后与抗PSCA半胱氨酸双抗体(A2cDb)偶联以及小动物成像。[F]SFB放射化学的三步一锅法放射性合成适用于批量微流控平台,反应液滴夹在EWOD芯片的两个平行板之间,并进行了优化。具体而言,发现前体与碱的比例、液滴体积、试剂浓度、反应时间和蒸发时间是关键参数。在EWOD芯片上成功合成了[F]SFB,放射化学产率为39±7%(n = 4),总合成时间约为120分钟([F]氟化物活化、[F]氟化、水解和偶联反应、HPLC纯化、干燥和重新配制)。[F]SFB的重新配制和稳定步骤对于获得33.1±12.5%(n = 3)的高蛋白标记效率很重要。一项小动物免疫PET初步研究表明,[F]SFB-PSCA双抗体偶联物在PSCA阳性人前列腺癌异种移植瘤中显示出特异性摄取。EWOD放射性合成仪紧凑占地面积的成功开发有可能使生物学家能够在标准实验室中自行生产感兴趣的PET探针。